National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

      

STATUTORY RULES.

  

1961. No. 59.

 

___________

  

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1959.*

I, THE ADMINISTRATOR of the Government of the- Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1959.

Dated this 27th day of April, 1961.

 

DALLAS BROOKS

Administrator.

By His Excellency's Command,

(Sgd.) Donald A. Cameron

Minister of State for Health.

__________

 

AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS. 

Commencement.

1. These Regulations shall come into operation on the first day of May,1961.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by inserting after the word—

"Chloroxylenol."

the words—

"Chlortetracycline Injection."; and

(b) by omitting the word—

"Diiodohydroxyquinoline.".

–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––

* Notified in the Commonwealth Gazette on, 28th April 1961.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102.

2700/61.—PRICE 8D. 8/20.4.1961.

Second and Third schedules.

3. The Second and Third Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

SECOND SCHEDULE.

Regulation 10 (3.).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Acetone B.P.C..........................................	Zinc Sulphate B.P. with Sulphurated Potash B.P.C., Acetone B.P.C., Glycerin B.P. and Distilled Water B.P.
	Magenta B.P.C. with Boric Acid B.P., Phenol B.P., Resorcinol B.P., Acetone B.P.C., Industrial Methylated Spirits B.P. and Water
Dried Aluminium Hydroxide Gel. B.P.......	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Aluminium Hydroxide Gel. B.P.................	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
Aluminium Powder...................................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Amiphenazole Hydrobromide....................	—
Amiphenazole Hydrochloride A.P.F. 1955.	—
Analysis Paper (Diabetic)..........................	—
Aneurine Hydrochloride B.P. ....................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Ascorbic Acid B.P....................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Bacitracin B.P..........................................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Bacitracin B.P. with Ophthalmic Phosphate Buffer Solution
	Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Bendrofluazide.........................................	—
Benethamine Penicillin.............................	Benthamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkonium Chloride............................	—
Benzathine Penicillin B.P..........................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P.................................	Fortified Procaine Penicillin Injection B.P.
	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Stretptomycin Sulphate B.P.
	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P.....................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P.
	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Bismuth Subnitrate B.P.C..........................	Resorcinol B.P. with Bismuth Subnitrate B.P.C., Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Busulphan................................................	—
Butabarbital Sodium..................................	—
Carbromal B.P..........................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P................................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water
	Chloramphenicol B.P. with Propylene Glycol B.P.
	Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Chlorpromazine Hydrochloride B.P............	—
Chlortetracycline Calcium.........................	—
Chlortetracycline Hydrochloride B.P..........	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Oil of Citronella........................................	Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water
Clemizole.................................................	—
Cortisone Acetate B.P...............................	—
Demethylchlortetracycline Hydrochloride...	—
Dexamethasone Sodium Phosphate............	––
Dextrochlorpheniramine Maleate...............	––
Dicyclomine Hydrochloride.......................	––
Dienoestrol B.P.........................................	––
Diethyl Dithiolisophthalate........................	––
Diiodohydroxyquinoline B.P......................	––
Diphenylthiourca......................................	—
Diphtheria and Pertussis Vaccine B.P.........	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria Vaccine B.P.............................	Diphtheria and Pertissus Vaccine B.P.
	Diphtheria, Tetanus and Pertussis Vaccine B.P.
	Diphtheria Vaccine B.P. with Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed
Ergotamine Tartrate B.P............................	Ergotamine Tartrate B.P. with Caffeine B.P.
Erythromycin B.P......................................	––
Ferrous Aminoacetosulphate......................	––
Ferrous Succinate......................................	––
Guanethidine Sodium ...............................	––
Haemophilus Influenza Bacterial Serum.....	––
Hamamelis Dry Extract.............................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hexocyclium Methyl Sulphate...................	—
Hydrocortisone B.P...................................	––
Isoprenaline Hydrochloride........................	—
Isopropamide Iodide..................................	––
Lofenalac.................................................	—
Mercuric Oxide Eye Ointment B.P.............	––
Methscopolamine Bromide .......................	––
Methylprednisolone...................................	—
Naphazoline Nitrate B.P............................	Antazoline Hydrochloride B.P. with Naphazoline Nitrate B.P.
Neomycin Sulphate B.P.............................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Nicotinamide B.P. ....................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Oestrone...................................................	—
Oleandomycin...........................................	Tetracycline with Oleandomycin
Oleoresin Capsicum..................................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Oxyphencyclimine Hydrochloride...............	—
Oxyphenonium Bromide.............................	—
Oxytetracycline Hydrochloride B.P.............	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C....................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Pancreatin B.P...........................................	—
Pentolinium Tartrate B.P............................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidine Hydrochloride B.P.......................	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
Pertussis Vaccine B.P.................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
	Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P......................	—
Phenoxymethylpenicillin (Benzathine Salt)..	––
Phenoxymethylpenicillin (Calcium Salt)......	––
Phenoxymethylpenicillin (Hydrabamine Salt)	—
Phenoxymethylpenicillin (Potassium Salt)...	—
Phenylephrine Hydrochloride B.P...............	Phenylephrine Hydrochloride B.P. with Benzocaine B.P., Bismuth Subgallate, Zinc Oxide B.P., Hamamelis Dry Extract, Tannic Acid B.P., Menthol B.P., Boric Acid B.P. and Oil of Theobroma B.P.
Polymyxin B. Sulphate B.P.........................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P.
	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
	Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer
	Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P.
	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Prednisolone B.P........................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Prednisolone Phosphate..............................	––
Prednisone B.P...........................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P........................	Procaine Hydrochloride B.P. in Normal Saline Tetracycline and Procaine Injection B.P.
Pyridine Aldoxime Methiodide...................	––
Pyrimido-Pyrimidine..................................	—
Pyrrolidino-Methyl-Tetracycline.................	—
Rauwolfia Alkaloids ..................................	—
Reserpine B.P............................................	—
Riboflavine B.P..........................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Sobee........................................................	—
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride in Water for Injection B.P.	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P.....	Compound Sodium Lactate Injection B.P. with Dextrose B.P.

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Sodium Lauryl Sulphate B.P.......................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P.........................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
	Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.
Sulphadimidine B.P....................................	Streptomycin Sulphate B.P. with Normal Saline
	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphamerazine B.P...................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphacetamide .........................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphathiazole...........................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Terpineol B.P.............................................	Solution of Chloroxylenol B.P.
Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed	Diphtheria Vaccine B.P. with Tetanus Toxoid,
	Purified Aluminium Phosphate Adsorbed
Tetanus Vaccine B.P..................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P..................	Tetracycline Hydrochloride B.P. with Nystatin
	Tetracycline and Procaine Injection B.P.
	Tetracycline Hydrochloride B.P. with a buffering agent
	Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline...............................................	Tetracycline with Oleandomycin
Thenalidine ...............................................	Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C.........................	Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Triamcinolone............................................	—
Trifluoperazine..........................................	—
Tricyclamol Chloride.................................	—
Troxidone B.P............................................	—
Typhoid Para-Typhoid A and B Vaccine B.P.	Typhoid Para-Typhoid A, B and C Vaccine B.P.
Tyrothricin................................................	Tyrothricin with a buffering agent
Concentrated Vitamin A Solution B.P.........	Concentrated Vitamins A and D Solution B.P.
Concentrated Vitamin D Solution B.P.........	Concentrated Vitamins A and D Solution B.P.
Vitamin D..................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Xylene B.P.C. 1949....................................	Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water
Yellow Mercuric Oxide B.P........................	Mercuric Oxide Eye Ointment B.P.

_______________

THIRD SCHEDULE.

Regulation 11.

PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.
Acetazolamide Sodium.	Catechu Tincture, B.P.C.
Acetone, B.P.C.	Cetyl Alcohol Compound.
Acetyl-Sulphamethoxypyridazine.	Charcoal.
Aconite Liniment, B.P.C.	Chiniofon, B.P. 1948.
Acriflavine, B.P. 1948.	Chlorambucil.
Adrenaline Hydrochloride Solution, B.P.1953.	Chlorazanil.
Adrenaline in Oil.	Chlormerodrin.
Adrenaline Mucate.	Chlorpheniramine Maleate.
Agar, B.P.C.	Chlorpropamide.
Aloes Pill B.P. 1948.	Chlortetracycline Calcium.
Aloin, B.P. 1953.	Chlorothiazide.
Aloxidone.	Clemizole Hydrochloride.
Aluminium Acetate Solution, B.P.C.	Cloves, Concentrated Infusion, B.P.C.
Aluminium Powder.	Codeine, B.P.C.
Amidopyrin, B.P.C.	Cod Liver Oil Emulsion, B.P. 1953.
Amiphenazole Hydrobromide.	Colchicine Salicylate.
Amiphenazole Hydrochloride, A.P.F. 1955.	Colocynth and Hyoscyamus Pill, B.P.C.
Ammonium Acetate, Strong Solution, B.P. 1953.	Colocynth, B.P.C.
Ammonium Bicarbonate, B.P. 1953.	Colocynth Compound Powder Extract, B.P.C.
Ammonium Bromide, B.P.C.	Compound Effervescent Powder, B.P. 1953.
Amphotericin B.	Creosote, B.P. 1953.
Amylobarbitone Sodium, B.P.C.	Crude Coal Tar.
Analysis Paper (Diabetic).	Cyclophosphamide.
Androstanolone.	Cycloserine.
Aromatic Ammonia Solution, B.P.C.	Cycrimine Hydrochloride.
Aromatic Ammonia Spirit, B.P. 1953.	D-Cycloserine.
Aurothioglucose.	Darrow's Solution.
Balsam of Peru, B.P.C.	Demethylchlortetracycline Hydrochloride.
Beeswax, Yellow, B.P.C.	Desacetyl-Lanatoside, C.
Belladonna Suppository, B.P. 1948.	Dexamethasone.
Bemegride, A.P.F. 1955.	Dexamethasone Sodium Phosphate.
Bendrofluazide.	Dextran Iron.
Benzalkonium Chloride.	Dextrin Iron.
Benzoinated Lard, B.P.C.	Dextrochlorpheniramine Maleate.
Bephenium Hydroxynaphthoate.	Dextrose in 1/5 Normal Saline.
Bismuth Carbonate B.P. 1953.	Dicyclomine Hydrochloride.
Bismuth Glycollylarsanilate.	Diethazine Hydrochloride.
Bismuth Subgallate, B.P. 1953.	Dithiazanine Iodide.
Bismuth Subnitrate, B.P.C.	Diethyl Dithiolisophthalate.
Bretylium Tosylate.	Digitoxin, B.P.C.
Buchu Concentrated Infusion, B.P.C.	Dihydroergotamine.
Busulphan.	Dihydromorphinone Hydrochloride, B.P.C. 1949.
Butabarbital Sodium.	Dihydrotachysterol.
Butyl Aminobenzoate, B.P. 1953.	Diphenylthiourea.
Caffeine Citrate. B.P.C.	Diphtheria Toxoid Purified.
Cajuput Tincture, B.P.C.	Disodium Dicthylstilboestrol Diphosphate.
Calamine Cream, A.P.F.	Disodium Dihydrogen Versenate.
Calcium Aurothiomalate.	Ephedrine Sulphate, B.P.C.
Calcium Di-Oxytetracycline.	Ergot Liquid Extract, B.P.C.
Calcium Para-Aminosalicylate, B.P.C.	Erythrityltetranitrate, B.P.C. 1949.
Calcium Phosphate, B.P. 1953.	Erythromycin Glucoheptonate.
Calumba Concentrated Infusion, B.P. 1948.	Erythromycin Propionate.
Calumba Tincture, B.P. 1948.	Erythromycin Stearate.
Capsicum Ointment. B.P.C.	Ether Nitrous Spirit, B.P.C.
Capsicum Tincture. B.P.C.
Caramiphen Hydrochloride.
Cardamom Aromatic Tincture, B.P.C.

THIRD SCHEDULE—continued.

Ferrous Phosphate Compound Syrup, B.P.C.	Nystatin.
Oestradiol Dipropionate.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.	Oestrone.
	Oleandomycin.
Ferrous Succinate.	Oleoresin Capsicum.
Fludrocortisone Acetate.	Orange Peel Infusion Concentrated, B.P. 1948.
Fluoxymesterone.
Formyl-Tetrahydropteroyl Glutamic Acid.	Orange Peel infusion Concentrated,
Fructose, B.P. 1948.	Compound, B.P.C.
Gall with Opium Ointment, B.P.C.	Ox-Bile Extract, B.P., 1948
Gelesmium Tincture, B.P.C.	Oxymel, B.P.C.
Gentian Violet.	Oxymel of Squill, B.P.C.
Glucose Liquid, B.P. 1953.	Oxyphencyclimine Hydrochloride.
Glycerophosphates Compound Syrup, A.P.F.	Oxyphenonium Bromide.
Oxytetracycline I.M.
Guanethidine Sodium.	Pancrex 5.
Haemophilus Influenza Bacterial Serum.	Para-Aminosalicyclic Acid.
Hamamelis Dry Extract.	Paraben Ophthalmic Phosphate Buffer, A.P.F.
Heparin Retard.
Hexachlorophene, 3% with Entsufon.	Paraben Ophthalmic vehicle, A.P.F.
Hexachlorothiazide.	Papaveretum, B.P.C.
Hexocyclium Methyl Sulphate.	Benzylpenicillin in Oil.
Hexoestrol.	Penicillin Benethamine.
Hydrocortisone Sodium Succinate.	Penicillinase.
Hydrocyanic Acid Dilute, B.P.C.	Pentacrythritol Tetranitrate.
Hydroflumethiazide.	Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).
Hydroxychloroquine Sulphate.
Hypophosphorous Acid Dilute, B.P.C.	Phemitone, B.P. 1953.
Insulin Isophane (N.P.H.).	Phenazone, B.P.C.
Insulin Special P (Pig).	Phenoxymethylpenicillin (Benzathine Salt).
Iodochlorhydroxyquinoline.	Phenoxymethylpenicillin (Calcium Salt).
Iodoform B.P.C.	Phenoxymethylpenicillin (Potassium Salt).
Iodoform Suppository, B.P. 1948.	Phenoxymethylpenicillin (Hydrabamine Salt).
Ipomoea Resin.	Phensuximide.
Iron Carbonate Saccharated, B.P.C.	Phenylbutazone.
Iron Oxide Saccharated.	Phthalysulphacetamide.
Isoprenaline Hydrochloride.	Pholcodine, B.P.C.
Isopropamide Iodide.	Pholcodine Citrate Syrup, B.P.C.
Lobelia Ethereal Tincture, B.P.C.	Piperazine Citrate.
Lofenalac.	Pituitary (Posterior Lobe).
Magenta, B.P.C.	Potash Sulphurated, B.P.C.
Magnesium Bicarbonate Solution, B.P 1948.	Potassium Chlorate, B.P.C.
Mecamylamine.	Prednisolone Phosphate.
Mecholyl Chloride.	Prednisolone Sodium Hemisuccinate.
Mercaptomerin Sodium.	Probenecid.
Mercaptopurine.	Prophenpyridamine Para-Aminosalicylate.
Mercuric Chloride, B.P. 1953.	Protamine Sulphate.
Mercurous Chloride Ointment, B.P. 1948.	Protoveratrines A.
Mercury Compound Ointment, B.P.C.	Pyridine Aldoxime Methiodide.
Methenamine Mandelate.	Pyridostigmine Bromide.
Methorphinan.	Pyridoxine Hydrochloride, B.P.C.
Methotrexate.	Pyrimido-Pyrimidine.
Methscopolamine Bromide.	Pyrrolidino-Methyl-Tetracycline.
Methyl Androstanolone.	Quassia Tincture, B.P. 1948.
Methyl Atropine Nitrate.	Rauwolfia Alkaloids.
Methyl Prednisolone.	Ristocetin.
Methylandrostenediol.	Salicylazosulphapyridine.
Myrrh, B.P.C.	Senega Concentrated Infusion, B.P.C.
Myrrh Tincture, B.P.C.	Senna Compound Mixture, B.P.C.
Nicoumalone.	Senna Leaf Concentrated Infusion, B.P.C.
Nitrofurantoin.	Siberian Fir Oil, B.P.C. 1949.
Nitromin.	Silver Picrate, B.P.C. 1949.
Norethandrolone.	Silver Protein Mild, B.P.C.
Nux Vomica Extract, Dried, B.P. 1953.

Soap Curd, B.P.C.

THIRD SCHEDULE—continued.

Soap Hard, B.P.C.	Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.
Sobee.
Sodium Calcium Edetate.	Tetracycline.
Sodium Carbonate Exsiccated, B.P.C.	Thenalidine.
Sodium Folate.	Theobromine, B.P.C.
Sodium Lactate.	Theobroma Prepared, B.P.C.
Sodium Nitrite, B.P.C.	Thiacetazone.
Sodium Oleate Acid.	Thiouracil, B.P. 1948.
Sodium Tauroglycocholate.	Thyrotropin.
Sorbolene, A.P.F.	Tiger Snake Antivenene.
Spiramycin.	Tolbutamide.
Squill Tincture.	Tretamine.
Squill Vinegar, B.P. 1948.	Triamcinolone.
Strophantus Tincture, B.P. 1948.	Tricyclamol Chloride.
Strychnine, B.P.C.	Triethanolamine Trinitrate.
Sulphacetamide.	Triethylene Thiophosphoramide.
Sulphadiazine Sodium.	Trifluoperazine.
Sulphadimethoxine.	Trimetaphan Camphorsulphonate.
Sulphamethoxypyridazine.	Trinitrophenol, B.P.C.
Sulphafurazole.	Tripolidine Hydrochloride.
Sulphamethizole.	Tyrothrycin.
Sulphaphenazole.	Valerian Ammoniated Tincture, B.P.C.
Sulphathiazole.	Vasopressin Tannate in Oil.
Sulphapyridine, B.P.C.	Veriloid.
Sulphuric Acid Dilute, B.P.C.	Vitamin A.
Syntocinon.	Vitamin D.
Talc Purified, B.P.C.	Vitamin K1.
Testosterone Oenanthate.	Xylene, B.P.C. 1949.

Fifth Schedule.

4.The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—

FIFTH SCHEDULE.

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Amiphenazole Hydrobromide	As an antidote to barbiturate and other hypnotic poisons
Amiphenazole Hydrochloride A.P.F. 1955
Amphotericin B .................................................	Systemic fungal infections
Androstanolone .................................................	Mammary carcinoma
Aneurine Hydrochloride Tablets B.P...................	Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P..................................	Any disease or condition in a Pensioner
Bemegride A.P.F. 1955.......................................	As an antidote to barbiturate and other hypnotic poisons
Busulphan .........................................................	The leukaemias
Calciferol Tablets B.P.........................................	Any disease or condition in a pensioner
Calciferol Solution B.P.......................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylate B.P.C...................	Tuberculosis
Caramiphen Hydrochloride.................................	Parkinsonism
Chlorambucil ....................................................	Malignant lymphoma and related conditions

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act.
Chloramphenicol Capsules B.P..........	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
	Bacterium coli meningitis, if other forms of treatment are unsuccessful
	Brucellosis
	Granuloma inguinale
	Friedlander bacillus infection
	Haemophilus influenzae infections
	Laryngo-tracheo-bronchitis, acute
	Lymphogranuloma venereum
	Salmonella infections
	Staphylococcal infections
	Surgical conditions of the bowel (pre-operative and post-operative)
	Typhoid fever
	Typhus and other rickettsial diseases
	Urinary tract infections due to gram negative bacilli that arc resistant to the Sulphonamides
	Whooping cough (Haemophilus pertussis)
	As an alternative to the Penicillins in a person sensitive to the Penicillins
	Severe gastro-enteritis in a child under the age of sixteen years
Chloramphenicol B.P., Injection ........	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol B.P., Oral Suspension	A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlortetracycline Capsules B.P. ........	As an alternative to the Penicillins in a person sensitive to the Penicillins
	Actinomycosis
	Amoebiasis
	Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
	Bronchiectasis
	Brucellosis
	Chancroid
	Fibrocystic disease of the pancreas
	Granuloma inguinale
	Friedlander bacillus infections
	Leptospirosis
	Lymphogranuloma venereum
	Mucoviscidosis
	Pneumonia that is resistant both to the Penicillins and the Sulphonamides
	Primary atypical pneumonia
	Psittacosis
	Puerperal infections
	Rat-bite fever (Spirillum minus)
	Staphylococcal infections
	Trachoma that is resistant to the Sulphonamides
	Typhus and other rickettsial diseases
	Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
	Whooping cough (Haemophilus pertussis)

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part vii. of the Act.
Chlortetracycline Calcium.................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Chlortetracycline B.P., Granules........
Cod Liver Oil, B.P.............................	Any disease or condition in a child under the age of twelve years or in a pensioner
Cod Liver Oil Emulsion B.P. 1953.....
Corticotrophin Injection B.P..............	With the written authority of the Director-General—
	A disease or condition specified in this column in relation to Cortisone Acetate
	The treatment of side effects of corticosteroid therapy
Cortisone Injection B.P......................	With the written authority of the Director-General—
	Anaemia, acquired haemolytic
	Addison's disease and other forms of adrenocortical hypoplasia
	Adrenalectomy, total
	Adrenogenital syndrome
	Cranial arteritis
	Cushing's syndrome, including hyperadrenocorticalism
	Dermatitis, acute exfoliative, associated with drug therapy
	Dermatomyositis
	Encephalomyelitis
	Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
	Hansen's disease
	Hepatitis, progressive or continuing, proven by biopsy or biochemistry
	The leukaemias
	Nephritis, type II.
	Nephrotic syndrome
	Neuro-myelitis optica
	Optic neuritis following removal of tumor of the brain
	Panhypopituitarism
	Pemphigus
	Periarteritis nodosa
	Pseudohermaphroditism
	Purpura, Henoch's
	Purpura, thrombocytopenic
	Rheumatic carditis, acute
	Salaam convulsions and hypsarrythmia
	Sarcoidosis
	Scleroderma
	Splenic neutropenia and agranulocytosis
	Status asthmaticus
	Steroid therapy prior to operation in patients under steroid therapy
	Still's disease in a child under the age of sixteen years
	Sympathetic ophthalmitis
	Systemic lupus erythematosus
	Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
	Ulcerative colitis proven by sigmoidoscopy or radiological report
	Uveitis, posterior

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Tablets B.P........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength)	Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgramme strength	Neuroblastoma
Cyclosphosphamide..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine.......................................
D-Cycloserine...................................
Demethylchlortetracycline Hydrochloride	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Deoxycortone Acetate B.P.................	Addison's disease
Deoxycortone Acetate Injection B.P...	Total adrenalectomy
Deoxycortone Acetate Implant B.P.....
Dexamethasone................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Dexamethasone Sodium Phosphate....
Dienoestrol B.P., Cream ...................	Any disease or condition in a pensioner
Dienoestrol Tablets B.P.....................	Carcinoma of the prostate
	Mammary carcinoma
	Any disease or condition in a pensioner
Diethyl Dithiolisophthalate................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Diiodohydroxyquinoline B.P., Vaginal Tablet	Trichomonal and monilial vaginitis
Dihydrostreptomycin Sulphate Injection B.P.	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol............................	Parathyroid deficiency
Diphenylthiourea..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Disodium Diethylstilboestrol Diphosphate	Carcinoma of the prostate
Erythromycin B.P.............................	Staphylococcal infections that arc resistant both to the Tetracyclines and to the Penicillins
Erythromycin Tablets B.P..................
Erythromycin Glucoheptonate...........
Erythromycin Propionate...................
Erythromycin B.P., Oral Suspension..	Staphylococcal infections that arc resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years
Erythromycin Stearate, Oral Suspension
Ethinyloestradiol Tablets B.P.............	Turner's syndrome
	Pre-menopausal castration
	Any disease or condition in a pensioner
Ethisterone Tablets B.P.....................	Turner's syndrome
	Habitual abortion
	Any disease or condition in a pensioner
Ferrous Aminoacetosulphate Syrup....	Any disease or condition in a child under the age of twelve years
Ferrous Succinate Syrup....................
Fludrocortisone Acetate.....................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymesterone ..............................	Mammary carcinoma
Folic Acid B.P..................................	Macrocytic anaemia
Folic Acid Tablets B.P......................	Sprue or the sprue-like syndrome

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Formyl-Tetrahydropteroyl Glutamic Acid	Any disease or condition in a patient receiving treatment in or at an approved hospital
Haemophilus Influenza Bacterial Serum..............................................................
Hexachlorophene, 3% with Entsufon..............................................................
Hydrocortisone Injection B.P..............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate..............................................................	Acute adrenal failure due to a medical or surgical crisis
	Stevens Johnson syndrome
Iron Oxide Saccharated..............................................................	As an alternative to Oral Iron in a person unable to take Oral Iron
Isoniazid Tablets B.P..............................................................	Hansen's disease
	Tuberculosis
Lofenalac..............................................................	With the written authority of the Director-General, phenylketonuria
Malt Extract B.P..............................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Malt Extract with Cod Liver Oil B.P...............................................................
Mercaptopurine..............................................................	The leukaemias
Methorphinan..............................................................	Inoperable cancer
Methotrexate..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methyl Androstanolone..............................................................	Mammary carcinoma
Methylandrostenediol..............................................................	Senile osteoporosis proven by radiography
Mustine Injection B.P..............................................................	Malignant lymphoma and related conditions
Nicotinamide Tablets B.P..............................................................	Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P..............................................................	Any disease or condition in a pensioner
Nitrofurantoin..............................................................	Urinary tract infections
Nitromin..............................................................	Malignant lymphoma and related conditions
Norethandrolone..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nystatin..............................................................	Proven monilia infections
Oxytetracycline Tablets B.P...............................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Injection B.P...............................................................
Oxytetracycline and Procaine Injection B.P.
Oxytetracycline J.M..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Calcium Di-Oxytetracycline..............................................................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Pancreatin B.P..............................................................	Fibrocystic disease of the pancreas
	Pancreatico-duodenectomy
Pancrex 5..............................................................	Fibrocystic disease of the pancreas
	Pancreatico-duodenectomy
Para-Aminosalicyclic Acid..............................................................	Tuberculosis
Phenoxymethylpenicillin B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension
Phenoxymethylpenicillin(Calcium Salt), Oral Suspension
Phenoxymethylpenicillin(Hydrabamine Salt), Oral Suspension
Phenoxymethylpenicillin (Potassium Salt), Oral Suspension
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Prednisolone Tablets B.P........................	With the written authority of the Director-General—
	Anaemia, acquired haemolytic
	Adrenogenital syndrome
	Cranial arteritis
	Cushing's syndrome, including hyperadrenocorticalism
	Dermatitis, acute exfoliative, associated with drug therapy
	Dermatomyositis
	Encephalomyelitis
	Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
	Hansen's disease
	Hepatitis, progressive or continuing, proven by biopsy or biochemistry
	The leukaemias
	Nephritis, type II.
	Nephrotic syndrome
	Neuro-myelitis optica
	Optic neuritis following removal of tumour of the brain
	Panhypopituitarism
	Pemphigus
	Periarteritis nodosa
	Pseudohermaphroditism
	Purpura, Henoch's
	Purpura, thrombocytopenic
	Rheumatic carditis, acute
	Salaam convulsions and hypsarrythmia
	Sarcoidosis
	Scleroderma
	Splenic neutropenia and agranulocytosis
	Status asthmaticus
	Steroid therapy prior to operation in patients under steroid therapy
	Still's disease in a child under the age of sixteen years
	Sympathetic ophthalmitis
	Systemic lupus erythematosus
	Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
	Ulcerative colitis proven by sigmoidoscopy or radiological report
	Uveitis, posterior
Methyl Prednisolone..............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Acetate B.P......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P.........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Progesterone Injection B.P...............................................................	Habitual abortion
Protoveratrines A..............................................................	Hypertensive crisis
Pyridine Aldoxime Methiodide..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Bromide..............................................................	Myasthenia gravis
Riboflavine Tablets B.P...............................................................	Any disease or condition in a pensioner
Ristocetin..............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Salicylazosulphapyridine..............................................................	Ulcerative colitis
Sobee..............................................................	With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P...............................................................	Tuberculosis
Sodium Aminosalicylate Tablets B.P...............................................................
Sodium Folate..............................................................	Macrocytic anaemia
	Sprue or the sprue-like syndrome
Stilboestrol B.P..............................................................	Carcinoma of the prostate
Stilboestrol Tablets B.P..............................................................

Mammary carcinoma
Any disease or condition in a pensioner
Streptomycin Sulphate B.P..............................................................	Bacillary dysentery that is resistant to the Sulphonamides
	Brucellosis
	Chancroid
	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
	Friedlander bacillus infections
	Haemophilus influenzae infections
	Plague
	Pseudomonas pyocyaneus infections
	Rat-bite fever (Streptobacillus moniliformis)
	Salmonella infections
	Surgical conditions of the bowel (pro-operative and post-operative)
	Surgical conditions of the thoracic organs
	Tuberculosis
	Tularaemia
	Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P...............................................................	A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium. B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Sulphadimethoxine Suspension..............................................................	Any disease or condition in a child under the age of twelve years
Sustanon..............................................................	Castration
Testosterone Implants B.P..............................................................	Mammary carcinoma
Testosterone Oenanthate..............................................................
Testosterone Propionate Injection B.P.	Castration
Testosterone Propionate B.P...............................................................	Kline felter Reifenstein Albright syndrome
Methyltestosterone Tablets B.P...............................................................	Mammary carcinoma
Tetracycline Capsules B.P..............................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets B.P..............................................................
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules
Tetracycline with Oleandomycin Capsules
Pyrrolidino-Methyl-Tetracycline

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Tetracycline Hydrochloride B.P............................................................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Tetracycline Hydrochloride B.P. with a buffering agent—Oral Suspension
Tetracycline Hydrochloride B.P. with a buffering agent—Paediatric Drops
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline Hydrochloride B.P. with Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thyrotropin...........................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triethylene Thiophosphoramide...........................................................
Tretamine...........................................................	Malignant lymphoma and related conditions
Trifluoperazine...........................................................	Any disease or condition in a pensioner
Trimetaphan Camphorsulphonate..	Hypotensive for anaesthesia
Veriloid...........................................................	Hypertensive crisis
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D	Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P............................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution B.P.
Concentrated Vitamin D Solution...........................................................
Vitamin K1...........................................................	As an antidote to anticoagulants

                     

_________________________

By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.